Release Date: 08 November 2024
The existing cancer therapies domain is undergoing a significant transformation due to the introduction of novel therapies, offering renewed hope to patients suffering from previously untreatable or resistant forms of the...
Release Date: 08 November 2024
The rapid advancements in immunotherapy, particularly antibody therapies, have paved the way for innovative approaches like tetraspecific antibodies. These unique molecules can bind to four different targets simultaneousl...
Release Date: 07 November 2024
Bispecific antibody drug conjugates (BsADCs) represent a groundbreaking innovation in targeted cancer therapy, combining the specificity of bispecific antibodies with the potent delivery mechanisms of drug conjugates. The...
Release Date: 23 October 2024
The global cancer antibody-drug conjugate (ADC) market is poised for significant growth in 2024. Following a robust valuation of approximately US$ 10 billion in 2023, the market is projected to surpass US$ 13 billion by t...
Release Date: 22 October 2024
Antibody drug conjugates (ADCs) are emerging as a promising approach in the treatment of lung cancer, particularly non-small cell lung cancer (NSCLC). Currently, there is only one approved ADC for lung cancer, with two ot...
Release Date: 11 October 2024
PROTACs, or proteolysis-targeting chimeras, represent a transformative approach in the field of therapeutic development, offering a novel mechanism for targeting disease-causing proteins. Unlike traditional small molecules that inhibit p...
Release Date: 11 October 2024
Breast cancer remains one of the most prevalent forms of cancer worldwide, affecting millions of women each year. Advances in treatment, such as hormonal therapies, chemotherapy, radiation, and targeted therapies, have si...
Release Date: 11 October 2024
Cancer drug resistance remains one of the most significant challenges in oncology, limiting the effectiveness of many therapies. Tumors often develop mechanisms to evade or resist treatment, resulting in disease progressi...
Release Date: 10 October 2024
The advent of Proteolysis-Targeting Chimeras (PROTACs) has marked a significant leap forward in the field of targeted cancer therapy. Traditional cancer treatments often rely on small molecule inhibitors, which function b...
Release Date: 04 October 2024
Precision medicine has heralded a novel epoch of change as well as challenge in the treatment of patients with cancer. Despite the fact that immunotherapies and targeted therapies have significantly improved the individua...
Release Date: 04 October 2024
In the dynamic landscape of cancer therapeutics, the emergence of precision medicine has revolutionized treatment paradigms, offering tailored approaches that capitalize on the unique molecular signatures of individual tu...
Release Date: 04 October 2024
In recent decades, advancements in immunology have led to the identification of novel immune checkpoints, significantly revitalizing cancer immunotherapy. One of the most promising candidates is the CD70 protein, which is...
Release Date: 04 October 2024
The pursuit of precision medicine has ushered in new possibilities for tailored therapies within the elaborate landscape of cancer treatment. Targeting Delta-Like Ligand 3 (DLL3) in cancer cells stands out as a particular...
Release Date: 26 September 2024
For an extended period, the awareness of immunotherapy has been related to targeting novel and unique agents and inhibiting their function. Compelling this hypothesis, researchers, in conjunction with scientists and docto...
Release Date: 26 September 2024
In the vast tapestry of India's healthcare landscape, the diagnostics industry has experienced remarkable growth, particularly in the sector of cancer diagnostics. This surge can be attributed to the increasing prevalence...